by Dorian Holden | Oct 21, 2019 | Markets
Four drug companies just reached a $260 million settlement to avoid a larger trial that blames them for fueling the raging opioid issues. In fact, lawsuits alleged the drug industry pushed opioid painkillers without warning of the risk of addiction. McKesson...
by Jamie Johnson | Oct 18, 2019 | Markets
PMI’s guidance disappointed investors, but the company still has room for further growth. This week, shares of Philip Morris fell after the company released its third-quarter earnings report. The tobacco company beat earnings estimates but lowered its guidance due to...
by Dorian Holden | Oct 18, 2019 | Markets
After months of trade war issues, recession fears, impeachment talk, and interest rate cuts, we’ll finally see how these issues affected companies’ bottom lines. And so far, it looks like many did very well. Banks for example had strong results, reflecting a healthy...
by Jamie Johnson | Oct 17, 2019 | Markets
During the third quarter, Netflix beat earnings expectations but still fell short on U.S. subscribers. On Wednesday, Netflix released its highly-anticipated earnings report, and the results were what most investors were looking to see. The company’s subscriber base...
by Dorian Holden | Oct 17, 2019 | Markets
Well, that was fast. Hours after the UK and European Union reached a Brexit deal, they’re realizing it doesn’t have a whole lot of support. Even as European Commission President Jean-Claude Juncker tweeted, “Where there is a will, there is a deal – we have...
by Dorian Holden | Oct 16, 2019 | Markets
Analysts may not be confident on Netflix (NFLX) earnings after the bell. But don’t count the stock out just yet. Many believe a good deal of negativity may have been priced in already with subscription growth concerns, poor second quarter results, and the...
Recent Comments